Vitamin K induces osteoblast differentiation through pregnane X receptor-mediated transcriptional control of the Msx2 gene (Retracted article. See vol. 34, pg. 918, 2014)

Vitamin K induces osteoblast differentiation through pregnane X receptor-mediated transcriptional control of the Msx2 gene (Retracted article. See vol. 34, pg. 918, 2014)
复制标题

DOI:
10.1128/mcb.00813-07
复制
发表时间:
2007-11-01
影响因子:
5.3
通讯作者:
Kato, Shigeaki
Kato, Shigeaki
中科院分区:
生物学2区
文献类型:
--
作者:
Igarashi, Mamoru;Yogiashi, Yoshiko;Kato, Shigeaki

文献摘要

被引文献

相似文献

维生素 K 是一种脂溶性维生素,可作为维生素 K 依赖性羧化酶的辅酶。除了其典型作用外,维生素 K 还能与类固醇和异生物质受体 (SXR)/孕烷 X 受体 (PXR) 结合并调节基因转录。为了确定维生素 K 的骨保护作用是否是 PXR/SXR 途径的结果,我们通过二维十二烷基硫酸钠-聚丙烯酰胺凝胶电泳筛选了用维生素 K2(甲基萘醌 4 [MK4])处理的成骨细胞系(MC3T3-E1)中的 PXR/SXR 靶基因。 MK4 诱导 MC3T3-E1 细胞的成骨细胞分化。 Msx2 是一种成骨细胞转录因子,被鉴定为 MK4 诱导基因。 Msx2 基因启动子的功能分析绘制了维生素 K 响应元件(PXR 响应元件 [PXRE])的图谱,该元件直接与 PXR/类视黄醇 X 受体 α 异二聚体结合。在染色质免疫沉淀分析中,PXR 与共激活因子 p300 一起被募集至 Msx2 启动子中的 PXRE。 MK4 结合的 PXR 与雌激素结合的雌激素受体 a 协同控制 Msx2 启动子的转录。 PXR 或 Msx2 的敲低减弱了 MK4 对成骨细胞分化的影响。因此,本研究表明,Msx2 是维生素 K 激活的 PXR 的靶基因,并表明 MK4 在人体中的骨保护作用至少部分介导维生素 K 信号传导的基因组途径。
Vitamin K is a fat-soluble vitamin that serves as a coenzyme for vitamin K-dependent carboxylase. Besides its canonical action, vitamin K binds to the steroid and xenobiotic receptor (SXR)/pregnane X receptor (PXR) and modulates gene transcription. To determine if the osteoprotective action of vitamin K is the result of the PXR/SXR pathway, we screened by two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis the PXR/SXR target genes in an osteoblastic cell line (MC3T3-E1) treated with a vitamin K2 (menaquinone 4 [MK4]). Osteoblastic differentiation of MC3T3-E1 cells was induced by MK4. Msx2, an osteoblastogenic transcription factor, was identified as an MK4-induced gene. Functional analysis of the Msx2 gene promoter mapped a vitamin K-responsive element (PXR-responsive element [PXRE]) that was directly bound by a PXR/retinoid X receptor alpha heterodimer. In a chromatin immunoprecipitation analysis, PXR was recruited together with a coactivator, p300, to the PXRE in the Msx2 promoter. MK4-bound PXR cooperated with estrogen-bound estrogen receptor a to control transcription at the Msx2 promoter. Knockdown of either PXR or Msx2 attenuated the effect of MK4 on osteoblastic differentiation. Thus, the present study suggests that Msx2 is a target gene for PXR activated by vitamin K and suggests that the osteoprotective action of MK4 in the human mediates, at least in part, a genomic pathway of vitamin K signaling.